CXCR3 antagonists
Details for Australian Patent Application No. 2001297717 (hide)
International Classifications
Event Publications
19 December 2002 Complete Application Filed
Priority application(s): 60/296,499 06.06.01 US; 60/255,241 11.12.00 US
17 April 2003 Application Open to Public Inspection
Published as AU-B-2001297717
23 February 2006 Assignment before Grant
Tularik Inc The application has been assigned to Amgen SF, LLC 2002
23 February 2006 Application Accepted
Published as AU-B-2001297717
22 June 2006 Standard Patent Sealed
14 August 2008 Assignment Registered
Amgen SF, LLC The patent has been assigned to Amgen Inc.
5 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2001297718-COMPOSITION AND METHOD FOR INCREASING WATER AND OIL REPELLENCY OF TEXTILES AND CARPET
2001297716-Implantable refillable and rate controlled drug delivery device
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser